FABRIS, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 20.108
EU - Europa 2.494
AS - Asia 2.135
AF - Africa 20
SA - Sud America 11
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 24.779
Nazione #
US - Stati Uniti d'America 20.097
CN - Cina 961
SG - Singapore 788
IT - Italia 685
FI - Finlandia 482
SE - Svezia 297
DE - Germania 295
VN - Vietnam 255
FR - Francia 248
UA - Ucraina 214
GB - Regno Unito 142
IN - India 46
HK - Hong Kong 44
NL - Olanda 39
IE - Irlanda 33
JP - Giappone 14
RU - Federazione Russa 12
ES - Italia 11
CA - Canada 9
MA - Marocco 9
IR - Iran 8
CH - Svizzera 7
CM - Camerun 6
TR - Turchia 6
AR - Argentina 5
AU - Australia 5
CZ - Repubblica Ceca 5
HU - Ungheria 5
BG - Bulgaria 3
BR - Brasile 3
EU - Europa 3
IL - Israele 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
CO - Colombia 2
GR - Grecia 2
HR - Croazia 2
KR - Corea 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BE - Belgio 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
KE - Kenya 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MX - Messico 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SC - Seychelles 1
SM - San Marino 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 24.779
Città #
Fairfield 3.477
Woodbridge 2.216
Houston 1.716
Ashburn 1.332
Ann Arbor 1.308
Seattle 1.288
Wilmington 1.233
Chandler 1.221
Cambridge 1.197
Jacksonville 1.031
Singapore 628
Princeton 522
Boardman 429
San Diego 350
Santa Clara 322
Dong Ket 255
Medford 222
Roxbury 220
Helsinki 193
Nanjing 192
Beijing 190
Padova 161
Des Moines 107
Hebei 65
Nanchang 65
Guangzhou 63
Norwalk 54
Shenyang 53
New York 49
Jiaxing 48
Hong Kong 41
London 41
Milan 38
Jinan 35
Rome 33
Dublin 32
Changsha 31
Redwood City 31
Tianjin 27
Kilburn 19
Ogden 15
Borås 12
Catania 12
Indiana 10
Kharkiv 10
Dearborn 9
Hefei 9
Bologna 8
Florence 8
Lanzhou 8
Palermo 8
Paris 8
Kunming 7
Orange 7
Rockville 7
Tappahannock 7
Detroit 6
Douala 6
Hangzhou 6
Legnaro 6
Naples 6
Ningbo 6
Osaka 6
Zhengzhou 6
Castiglione 5
Haikou 5
Pollena Trocchia 5
Rabat 5
San Francisco 5
Washington 5
Yellow Springs 5
Acton 4
Costa Mesa 4
Dresden 4
Dronten 4
Falls Church 4
Frankfurt am Main 4
Genoa 4
Guardiagrele 4
Hounslow 4
Messina 4
Monselice 4
Montesilvano Marina 4
Monza 4
Mykolayiv 4
Nutley 4
Perugia 4
Selargius 4
Selvazzano Dentro 4
Shanghai 4
Verona 4
Zurich 4
Ailoche 3
Amsterdam 3
Ardabil 3
Atlanta 3
Auburn Hills 3
Azzano San Paolo 3
Bellaterra 3
Bitonto 3
Totale 20.871
Nome #
Mappatura Genetica dell' Ipercolesterolemia Familiare: dati preliminari dell'esperienza padovana 247
Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles? 197
Low vitamin K1 intake in haemodialysis patients 195
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins 177
Vitamin K plasma levels determination in human health 173
Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process 172
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 168
Comparison of three different immunoassays in the diagnosis of heparin-induced thrombocytopenia. 161
Weight loss reduces anti-ADAMTS13 autoantibodies and improves inflammatory and coagulative parameters in obese patients 155
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. 149
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 144
Changes in Accident & Emergency Visits and Return Visits in Relation to the Enforcement of Daylight Saving Time and Photoperiod 143
Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus 140
Plasma exchange for the management of the catastrophic antiphospholipid syndrome: importance of the type of fluid replacement. 137
Thrombotic risk correlates with mutational status in true-essential thrombocythemia 133
Correlation between ADAMTS13 activity and neurological impairment in acute thrombotic microangiopathy patients 133
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 130
Diagnostic pathways of the complex patients: rapid intensive observation in an Acute Medical Unit. 128
Cigarette smoking is associated with decreased Bone Gla-protein (BGP) levels in hemodialysis patients. 127
Systemic mastocytosis and essential thrombocythemia: Case report and literature overview 127
Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS) 127
A novel germ-line mutation of c-mpl gene in a sporadic case of essential thrombocythemia 125
Intriguing outcome of JAK2V617F mutation seen in a patient with MYH9-related hereditary macrothrombocytopenia 125
Arg 304 Gln (FVII Padua) and Ala 294 Val mutations are equally present in patients with FVII deficiency and thrombosis. 120
Presence of anti-ADAMTS13 antibodies in obesity. 120
Bone marrow histology for the diagnosis of essential thrombocythemia in children: a multi-center Italian study 120
Alteration of liver enzymes is a feature of the MYH9-related disease syndrome. 119
Training of Italian emergency medicine residents in prehospital emergency medicine:state of the art and perspectives of improvement 119
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 117
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation. 117
Heparin-Induced Thrombocytopenia in Patients with Philadelphia-Negative Myeloproliferative Disorders and Unusual Splanchnic or Cerebral Vein Thrombosis 116
Platelet serotonin and platelet aggregation in the differential diagnosis of thrombocytosis 115
Selection of both normal and bleeding patients is indicated before desmopressin administration 115
Bernard-Soulier Syndrome: diagnosis by ELISA method using monoclonal antibodies in 2 new unrelated patients 112
Pediatric patients with essential thrombocythemia are mostly polyclonal and V617FJAK2 negative. 112
A tentative classification of factor XIII deficiency in two groups. 112
Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes 112
Declining trends in the incidence of hip fractures in people aged 65years or over in years 2000-2011 112
Clinical biological remission induced by rituximab in acute refractory chronic relapsing TTP. 112
Sindromi mieloproliferative croniche: La trombocitemia essenziale 111
A A386G biallelic GPIb alpha gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis 111
Biotin-avidin immobilization of platelet glycoproteins (BAIPG): a new capture assay for the detection of anti-platelet antibodies. 110
Multiple, relapsing thrombosis in a young man with primary thrombocytosis 110
Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors. 110
Link between von Willebrand factor multimers, relapses and coronary microcirculation in patients with thrombotic thrombocytopenic purpura in remission 110
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations. 109
The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients. 109
Heparin induced thrombocytopenia: Prevalence in a large cohort of patients and confirmed role of PF4/heparin complex as the main antigen for antibodies 108
Splenomegaly as the first manifestation of thyroid cancer metastases 107
Normal thrombopoietin and its receptor (c-mpl) genes in children with essential thrombocythemia. 107
Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the Jak2 (V617F) mutation 107
Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard-Soulier syndrome. 107
A 29-year-old woman with persistent thrombocytopenia 107
The significance of plasma and /or platelet activated products after apheresis procedures 107
Defective ADAMTS13 synthesis as a possible consequence of NASH in an obese patient with recurrent thrombotic thrombocytopenic purpura. 105
Plasma and platelet beta-thromboglobulin levels in patients with May-Hegglin anomaly 105
Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected 104
A case of Bernard-Soulier Syndrome due to a homozygous four bases deletion (TGAG) of GPIbalpha gene: lack of GPIbalpha but absence of bleeding. 103
The significance of thrombocytosis in old age 102
Normal and low molecular weight heparins: interaction with human platelets 102
A new ELISA method for the detection of serum bindable anti-platelet antibodies (SPBIG). 102
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 102
Two novel missense mutations in EPOR gene causes erythrocytosis in two unrelated patients 100
JAK2V617F mutation is common in old patients with polycythemia vera and essential thrombocythemia. 99
Spectrum of the Mutations in Bernard-Soulier Syndrome 99
New heterozygous variant in GP1BB gene is responsible for an inherited form of macrothrombocytopenia 99
Additional evidence against the presence of inhibitors in vit. K deficiency and in coumarin-treated patients. 98
Antiplatelet glycoprotein autoantibodies in patients with autoimmune diseases with and without thrombocytopenia. 98
Clinical and laboratory factors that affect the post-transfusion platelet increment 98
Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis. 98
Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies. 98
Familial thrombocythemia and/or thrombocytosis: apparently a rare disorder 97
Labeling of platelet surface glycoproteins with biotin derivatives 97
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 97
Heavy chain myosin 9-related disease (MYH9 -RD): Neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 96
A novel RUNX1 mutation with ANKRD26 dysregulation is related to thrombocytopenia in a sporadic form of myelodysplastic syndrome 96
Essential thrombocythemia in young adults: treatment and outcome of 16 pregnancies. 95
Combined factor VII and factor VIII deficiency due to a casual association of heterozygosis for factor VII deficiency and hemophilia A. 95
Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves. 95
Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study 95
Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura 95
Absence of interaction between rivaroxaban, tacrolimus and everolimus in renal transplant recipients with deep vein thrombosis or atrial fibrillation 95
HOW MANY CHILDREN WITH THROMBOCYTOSIS OF UNDEFINED ORIGIN HAVE A MYELOPROLIFERATIVE NEOPLASM? 94
A 40-years-old man with recurrent fainting, hypotension, lower limb edema and oliguria with body weight gain and secondary erythrocytosis 94
Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation: Implications for Risk and Therapy. 94
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 94
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect. 93
Clinical significance of beta-thromboglobulin in patients with high platelet count 93
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 93
Dabigatran antagonizes growth, cell-cycle progression, migration, and endothelial tube formation induced by thrombin in breast and glioblastoma cell lines 93
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 93
Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay. 93
Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: Report of four cases and review of the literature 92
Effect of busulfan on JAK2V617F allele burden. 92
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 92
Broken heart in elderly patients: two clinical observations. 91
Serum Thrombopoietin and cMpl Expression in Thrombocytopenia of Different Etiologies. 91
Use of a radioimmunoassay for 5-hydroxytryptamine (5-HT) in thrombocytosis 91
Idiopathic erythrocytosis: a study of a large cohort with a long follow-up 91
Genetic Diagnosis of Familial Hypercholesterolaemia: preliminary data from the University of Padua outpatient lipid clinic. 91
Totale 11.423
Categoria #
all - tutte 87.856
article - articoli 86.023
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 173.879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.230 0 0 0 0 0 0 401 544 984 582 433 286
2020/20214.208 299 336 299 251 139 208 67 449 505 549 421 685
2021/20224.315 104 478 389 504 205 266 159 478 249 84 398 1.001
2022/20232.676 683 189 88 275 398 308 17 215 315 33 124 31
2023/20241.210 64 152 118 115 81 99 63 50 43 22 191 212
2024/20252.134 29 469 347 239 901 147 2 0 0 0 0 0
Totale 25.031